A new ADHD Shared Care pathway for children and young people is now available in the Sydney Local Health District (SLHD).
This joint initiative between CESPHN and the SLHD Community Paediatric Service is designed to make it easier for general practitioners (GPs) to partner with specialist services in the ongoing management of attention deficit hyperactivity disorder (ADHD).
This model has been enabled by NSW reforms introduced in September 2025, which strengthened the role of GPs in ADHD management.
The shared care model provides clear guidance, streamlined communication, and practical tools to support GPs in prescribing and monitoring ADHD medications once a child or young person’s treatment has been stabilised.
Our goal is to ensure timely access to care, reduce bottlenecks in specialist clinics, and strengthen continuity for patients and families.
As part of the rollout, GPs will have access to:
Please refer to GP information: ADHD Shared Care information sheet.
If you or you practice wish to be involved and learn more about this initiative contact:
Jessica Porter
ADHD Clinical Nurse Consultant and Shared Care Coordinator, SLHD Community Paediatric Team
📧 Email: SLHD-ComPaedIntake@health.nsw.gov.au
📞 Phone: 9562 5400 (option 3)
Additional resources:
Immunisation Weekly Update: Promote Japanese Encephalitis Vaccination Ahead of Travel Measles Immunity Gaps: A Timely Reminder to Check Vaccine Status COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar Education Promote Japanese Encephalitis Vaccination Ahead of Travel Funded JE vaccination is available for eligible…
Immunisation Weekly Update: Capvaxive stock exhausted Current stocks of Capvaxive have been exhausted due to ongoing supply and distribution constraints, resulting in a temporary vaccine shortage. Further stock is anticipated to arrive in the coming weeks. Please ensure clinics or appointments for eligible patients are only booked when you have…
Immunisation Weekly Update: Capvaxive® supply constraints General practices are advised that there are currently national supply delays affecting Capvaxive® (adult pneumococcal vaccine). To help manage available stock, practices should only schedule vaccination appointments for eligible patients when adequate vaccine supplies are available on site. Supply constraints are expected to improve…
Immunisation Weekly Update: NSW Health Vaxigrip stock exhausted: temporary stock-sharing licence in place As of 20 July 2026, NSW Health has exhausted its available stock of Vaxgrip vaccine, which is funded for people aged 6 months to less than 5 years under the National Immunisation Program (NIP). NSW Health has…
Immunisation Weekly Update: Diphtheria vaccination for Aboriginal people and travellers Child vaccination FAQ resource Fatal meningococcal Y case in WA Education Diphtheria vaccination for Aboriginal people and travellers Recent diphtheria outbreaks in parts of Australia have prompted ATAGI to release updated advice regarding vaccination in outbreak settings. Clinicians should check…
